Journals / Anatolian Current Medical Journal / 2026 / Volume: 8 Issue: 6

Admission vitamin D status and 28-day mortality in sepsis: threshold dependence and nutritional confounding in a retrospective intensive care cohort

Hatice Zeynep Atlı(Ankara Etlik Şehir Hastanesi Department of Intensive Care Unit)0000-0002-3819-1442
Ayşe Müge Karcıoğlu(Ankara Etlik Şehir Hastanesi Department of Intensive Care Unit)0000-0002-2154-7975
Ülkü Yavuz Ersayın(Ankara Etlik Şehir Hastanesi Department of Anesthesiology and Reanimation)0000-0002-6813-5038
Emin Gemcioğlu(Ankara Etlik Şehir Hastanesi Department of Internal Medicine)0000-0001-9751-8452
Pages
—
Publication Date
2026-10-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The overall association was insensitive to the substitution value used for the 27.3% of measurements below the assay limit of quantification (LOQ, 3 ng/ml) and to multiple imputation; however, in the complete-case analysis restricted to quantifiable concentrations no dose response gradient remained (OR, 0.950; p=0.797), indicating that the signal is driven by concentrations below the LOQ rather than by a continuous gradient across the measurable range.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: Hypovitaminosis D is near-universal in critical illness, but whether it reflects a modifiable micronutrient deficit or the acute-phase response is unclear, and no accepted 25-hydroxyvitamin D 25(OH)D threshold exists.
📊
Key Findings & Data:We examined admission 25(OH)D and 28-day mortality in sepsis, testing dependence on cut-off choice and on nutritional status.
💡
Conclusion & Impact:The overall association was insensitive to the substitution value used for the 27.3% of measurements below the assay limit of quantification (LOQ, 3 ng/ml) and to multiple imputation; however, in the complete-case analysis restricted to quantifiable concentrations no dose response gradient remained (OR, 0.950; p=0.797), indicating that the signal is driven by concentrations below the LOQ rather than by a continuous gradient across the measurable range.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Critical illness · intensive care units · mortality

Abstract

Aims: Hypovitaminosis D is near-universal in critical illness, but whether it reflects a modifiable micronutrient deficit or the acute-phase response is unclear, and no accepted 25-hydroxyvitamin D 25(OH)D threshold exists. We examined admission 25(OH)D and 28-day mortality in sepsis, testing dependence on cut-off choice and on nutritional status. Methods: We retrospectively studied 267 adults admitted to a general intensive care unit (ICU) with sepsis as the admission diagnosis, who stayed at least 48 hours and had 25(OH)D measured on admission as part of the routine panel. The primary exposure was log-transformed continuous 25(OH)D; pre-specified Institute of Medicine categories and tertiles were secondary. Logistic regression was adjusted for age, gender, severity scores, comorbidity, albumin, and lactate. Results: Median 25(OH)D was 10.0 ng/ml; 75.7% were below 20 ng/ml. Mortality at 28 days was 52.1%. The overall association was insensitive to the substitution value used for the 27.3% of measurements below the assay limit of quantification (LOQ, 3 ng/ml) and to multiple imputation; however, in the complete-case analysis restricted to quantifiable concentrations no dose response gradient remained (OR, 0.950; p=0.797), indicating that the signal is driven by concentrations below the LOQ rather than by a continuous gradient across the measurable range. Each doubling of 25(OH)D carried 22% lower adjusted odds of death [odds ratio (OR), 0.775; 95% confidence interval (CI), 0.645-0.931; p=0.006]. Risk was confined to the lowest tertile (≤5.0 ng/ml; adjusted OR, 2.460; 95% CI, 1.168-5.184; p=0.018), with middle and highest tertiles indistinguishable. The pre-specified ≤12 ng/ml category was non-significant after adjustment (p=0.097), whereas moving the boundary to <12 or ≤10 ng/ml made it significant. Effect sizes were near-identical in hypoalbuminemic and normoalbuminemic strata. Discrimination was poor (area under the curve, 0.570). Conclusion: Low admission 25(OH)D is independently associated with 28-day mortality in sepsis, but the signal is driven by values below the assay limit of quantification rather than by a gradient across the measurable range, and conventional cut-offs provided no prognostic separation. The limited available nutritional proxies do not explain it, and 25(OH)D is not usable as a stand-alone prognostic test.

🔖

Cite This Article

Atlı, H. Z., Karcıoğlu, A. M., Ersayın, Ü. Y., Gemcioğlu, E. (2026). Admission vitamin D status and 28-day mortality in sepsis: threshold dependence and nutritional confounding in a retrospective intensive care cohort. Anatolian Current Medical Journal, Volume: 8 Issue: 6. https://ajindex.com/articles/1667869

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (30)

  1. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315(8):801-810. doi:10.1001/jama.2016.0287
  2. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-211. doi:10.1016/S0140-6736(19)32989-7
  3. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486-552. doi:10.1097/CCM.0000000000002255
  4. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006; 311(5768):1770-1773. doi:10.1126/science.1123933
  5. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007;179(4):2060-2063. doi:10.4049/jimmunol.179.4.2060
  6. Amrein K, Papinutti A, Mathew E, Vila G, Parekh D. Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa. Endocr Connect. 2018;7(12):R304-R315. doi:10.1530/EC-18-0184
  7. Lee P, Eisman JA, Center JR. Vitamin D deficiency in critically ill patients. N Engl J Med. 2009;360(18):1912-1914. doi:10.1056/NEJMc0809996
  8. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008; 168(12):1340-1349. doi:10.1001/archinte.168.12.1340
  9. de Haan K, Groeneveld AB, de Geus HR, Egal M, Struijs A. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis. Crit Care. 2014;18(6): 660. doi:10.1186/s13054-014-0660-4
  10. Amrein K, Christopher KB, McNally JD. Understanding vitamin D deficiency in intensive care patients. Intensive Care Med. 2015;41(11): 1961-1964. doi:10.1007/s00134-015-3937-4
  11. Powe CE, Karumanchi SA, Thadhani R. Vitamin D-binding protein and vitamin D in blacks and whites. N Engl J Med. 2014;370(9):880-881. doi:10.1056/NEJMc1315850
  12. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011.
  13. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. doi:10.1210/jc.2011-0385
  14. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. doi:10.1210/clinem/dgae290
  15. Amrein K, Schnedl C, Holl A, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA. 2014;312(15):1520-1530. doi:10.1001/jama.2014.13204
  16. Amrein K, Parekh D, Westphal S, et al. Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study). BMJ Open. 2019;9(11):e031083. doi:10.1136/bmjopen-2019-031083
  17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. doi:10.1016/0021-9681(87)90171-8
  18. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829.
  19. Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707-710. doi:10.1007/BF01709751
  20. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z; Ad Hoc ESPEN Working Group. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22(3):321-336. doi:10.1016/s0261-5614(02)00214-5
  21. Kondrup J, Allison SP, Elia M, Vellas B, Plauth M; Educational and Clinical Practice Committee, European Society of Parenteral and Enteral Nutrition (ESPEN). ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22(4):415-421. doi:10.1016/s0261-5614(03)00098-0
  22. Heyland DK, Dhaliwal R, Jiang X, Day AG. Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Crit Care. 2011;15(6):R268. doi:10.1186/cc10546
  23. Rahman A, Hasan RM, Agarwala R, Martin C, Day AG, Heyland DK. Identifying critically-ill patients who will benefit most from nutritional therapy: further validation of the "modified NUTRIC" nutritional risk assessment tool. Clin Nutr. 2016;35(1):158-162. doi:10.1016/j.clnu.2015.01.015
  24. Kondrup J. Nutritional-risk scoring systems in the intensive care unit. Curr Opin Clin Nutr Metab Care. 2014;17(2):177-182. doi:10.1097/MCO.0000000000000041
  25. Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48-79. doi:10.1016/j.clnu.2018.08.037
  26. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006;25(1):127-141. doi:10.1002/sim.2331
  27. National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Ginde AA, Brower RG, et al. Early high-dose vitamin D3 for critically ill, vitamin D-deficient patients. N Engl J Med. 2019;381(26):2529-2540. doi:10.1056/NEJMoa1911124
  28. Quraishi SA, De Pascale G, Needleman JS, et al. Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: a randomized, placebo-controlled trial. Crit Care Med. 2015;43(9):1928-1937. doi:10.1097/CCM.0000000000001148
  29. Zheng WH, Shi JH, Yu DX, Huang HB. Vitamin D supplementation in critically ill patients: a meta-analysis. Front Nutr. 2025;12:1505616. doi:10.3389/fnut.2025.1505616
  30. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957-2963. doi:10.1001/jama.270.24.2957